Lazard Asset Management’s ImmunityBio IBRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $91K | Buy |
+34,788
| New | +$91K | ﹤0.01% | 1887 |
|
|
2025
Q1 | – | Sell |
-98
| Closed | – | – | 2426 |
|
|
2024
Q4 | $0 | Hold |
98
| – | – | ﹤0.01% | 2393 |
|
|
2024
Q3 | $0 | Sell |
98
-172
| -64% | – | ﹤0.01% | 2353 |
|
|
2024
Q2 | $1K | Sell |
270
-12,749
| -98% | -$47.2K | ﹤0.01% | 2149 |
|
|
2024
Q1 | $68K | Buy |
13,019
+6,593
| +103% | +$34.4K | ﹤0.01% | 1653 |
|
|
2023
Q4 | $31K | Buy |
6,426
+259
| +4% | +$1.25K | ﹤0.01% | 2005 |
|
|
2023
Q3 | $10K | Buy |
6,167
+268
| +5% | +$435 | ﹤0.01% | 2142 |
|
|
2023
Q2 | $16K | Buy |
+5,899
| New | +$16K | ﹤0.01% | 2139 |
|